LRP1 and central nervous system cancer: Importantly, this peptide exploits the low density lipoprotein receptor related protein-1 (LRP-1)—expressed both by brain microcapillary endothelial cells and by glioma—to gain access to the brain parenchyma via receptor-mediated transcytosis [39].